Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Recovery

News
More Dangerous Substances Require More Proactive Efforts, Officials Say
04/12/2023
With deaths involving fentanyl and xylazine rising, NIDA Director Nora Volkow, MD, NIH Director Lawrence Tabak, DDS, PhD, and NIAAA Director George Koob, PhD, presented research updates and developments in substance use disorder treatment to...
With deaths involving fentanyl and xylazine rising, NIDA Director Nora Volkow, MD, NIH Director Lawrence Tabak, DDS, PhD, and NIAAA Director George Koob, PhD, presented research updates and developments in substance use disorder treatment to...
With deaths involving fentanyl...
04/12/2023
Addiction Professional
News
Medication-Assisted and Abstinence-Based Treatment Approaches Can Share Common Ground
04/11/2023
At the Rx Summit, presenters Robert DuPont, MD, Cara Poland, MD, MEd, FACP, DFASAM, and Gresha Eberly, CPRC, explained the philosophical conflicts between different approaches to addiction treatment and what providers of each can learn from...
At the Rx Summit, presenters Robert DuPont, MD, Cara Poland, MD, MEd, FACP, DFASAM, and Gresha Eberly, CPRC, explained the philosophical conflicts between different approaches to addiction treatment and what providers of each can learn from...
At the Rx Summit, presenters...
04/11/2023
Addiction Professional
News
Federal Officials Champion Multifaceted Response to Addiction Crisis
04/11/2023
In an opening plenary session Monday afternoon at the Rx and Illicit Drug Summit, US Rep. Hal Rogers and FDA Commissioner Robert Califf, MD, MACC, said flipping the script on the opioid epidemic requires action on multiple fronts.
In an opening plenary session Monday afternoon at the Rx and Illicit Drug Summit, US Rep. Hal Rogers and FDA Commissioner Robert Califf, MD, MACC, said flipping the script on the opioid epidemic requires action on multiple fronts.
In an opening plenary session...
04/11/2023
Addiction Professional
Angela Huskey, PharmD, CPE
Perspectives
Polysubstance Crisis Calls for All-Hands-on-Deck Response
04/07/2023
With recent data showing the degree to which polysubstance use is fueling the addiction crisis, currently available tools and treatments may not fully address the potent drug combinations behind today’s overdoses.
With recent data showing the degree to which polysubstance use is fueling the addiction crisis, currently available tools and treatments may not fully address the potent drug combinations behind today’s overdoses.
With recent data showing the...
04/07/2023
Addiction Professional
News
Buprenorphine Initiation in ER Found Safe and Effective for Patients Using Fentanyl
03/31/2023
Findings from the National Institutes of Health-supported study indicate OUD treatment with buprenorphine can be safely started in an emergency department without triggering withdrawal, even among individuals who use stronger opioids.
Findings from the National Institutes of Health-supported study indicate OUD treatment with buprenorphine can be safely started in an emergency department without triggering withdrawal, even among individuals who use stronger opioids.
Findings from the National...
03/31/2023
Addiction Professional
News
FDA Approves Narcan for Over-The-Counter Use
03/29/2023
The US Food and Drug Administration (FDA) on Wednesday announced that it has approved Narcan, 4 milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. Narcan becomes the first naloxone product approved for use...
The US Food and Drug Administration (FDA) on Wednesday announced that it has approved Narcan, 4 milligram naloxone hydrochloride nasal spray for over-the-counter, nonprescription use. Narcan becomes the first naloxone product approved for use...
The US Food and Drug...
03/29/2023
Addiction Professional
News
Study Highlights Prevalence of Buprenorphine “Spiking” in Urine Screenings for OUD Patients
03/28/2023
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples...
03/28/2023
Addiction Professional
News
NIH-Backed Study Identifies Genetic Markers Underlying SUDs
03/24/2023
Researchers at Washington University in St. Louis, Missouri, have identified genes commonly inherited across addiction disorders, potentially paving the way for new treatment targets across multiple substance use disorders, including...
Researchers at Washington University in St. Louis, Missouri, have identified genes commonly inherited across addiction disorders, potentially paving the way for new treatment targets across multiple substance use disorders, including...
Researchers at Washington...
03/24/2023
Addiction Professional
News
Bupropion and Contingency Management Combination Could Help Curb Cocaine Use Among OUD Patients
03/21/2023
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management and bupropion, an antidepressant medication that is also used for smoking cessation, could be a treatment option for curbing cocaine use by patients who are in treatment for opioid use disorder, according to...
Pairing contingency management...
03/21/2023
Addiction Professional
News
Skin Disease Medication Also Effective in Alcohol Use Disorder Treatment
02/28/2023
A pill used to treat a common skin disease was found to reduce alcohol consumption by more than half among patients diagnosed with alcohol use disorder, according to findings published recently by researchers at Oregon Health & Science...
A pill used to treat a common skin disease was found to reduce alcohol consumption by more than half among patients diagnosed with alcohol use disorder, according to findings published recently by researchers at Oregon Health & Science...
A pill used to treat a common...
02/28/2023
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement